Apple has patented the Face ID feature in the Apple Watch smart watch

-
























At present, the Apple Watch smart clock authenticates the wearer by touching the skin. This means that the authentication process takes place as long as the clock is adhered to the user's skin, which in turn means that removing the watch from your wrist means the need to re-authenticate again, which is a process that can be a bit boring.
A patent was recently discovered by Patently Apple and Apple seems to be exploring the idea of ​​providing the Apple Watch with Face ID.

For those who have not heard of this feature before, it is a new facial recognition feature that first appeared with the iPhone X. It is expected that this feature will find its way to iPad tablets, so it will not be easy to think that it may find Has made its way to more Apple products, such as Apple Watch.

What makes this patent particularly interesting is that, according to Patently Apple, Apple believes that Apple has registered this patent while still working on Face ID because Apple refers to this feature in the patent as a "user identification", perhaps to prevent Infiltration Face ID. Apparently, Apple filed for the patent in 2016, which means it is not a very old patent.

However, since it is still patented, it is difficult to tell whether Apple will turn it into reality. Patents are sometimes filed to protect intellectual property and ideas, so it remains to be seen whether Apple is simply protecting itself or whether this patent embodies one of the future features that will reach Apple Watch, but what do you think, do you like the idea of ​​seeing Apple Watch with Face ID?

Comments

Post a Comment

Popular posts from this blog

One drug is anti-obesity, pain and depression

-
Image
erman scientists have discovered a promising anti-obesity, depression and chronic pain that scientists are working on to treat. Scientists from Germany point out that protein in the human body plays an important role not only in energy exchange but also in the development of depression and chronic pain. Researchers at the Darmstadt Technological University found that blocking FKBP51 inhibits the tendency to depression, obesity and chronic pain. Currently, Tacrolimus, obtained with the help of bacteria and similar proteins, FKBP51, is the basis of all drugs and drugs currently used to treat these diseases. Scientists have changed the substance to block only the FKBP51 protein, and are currently working on two versions of the drug: the first can overcome the blood barrier in the brain, specialized for the treatment of depression and chronic pain. The second will be to combat obesity. The products were tested only on laboratory animals and will soon begin clinical testing,
Read more

"Strange" star changed the paths of celestial bodies thousands of years ago!

-
Image
A recent study found that our ancient ancestors may have seen about 70,000 years ago, a spectacular sight in the night sky. The study says a small star, known as "Scholz", approached our solar system, sending comets and asteroids from the outer reaches of the solar system to its center. read more How did the first "mysterious" visitor arrive at our solar system How did the first "mysterious" visitor arrive at our solar system? As humans began to leave Africa, when the Neanderthals still lived on our planet, the dwarf star approached the Sun less than a light year ago, just 20 light years away from the sun, causing a comet crash in the Ort cloud. , The last layer in our solar system. It is likely that this star has been spotted for thousands of years, as a dim reddish light, glowing in the area around the "Big Dipper" galaxy also called "The Plow". Experts believe that the trajectories of a number of remote space rocks in
Read more

Russian artist Vladimir Machkov was appointed director of the "Tabakirka"

-
Image
The Russian artist Vladimir Machkov was the artistic director of Moscow's Tabakirka Theater, a theater founded by the late Soviet artist Oleg Tabakov, who was its artistic director for years. The "Tabakirka" theater was established in Moscow in 1987. Vladimir Machakov acted as a stage actor and director after graduating from the Tekovov Theater, a theater of the Chekhov Theater. He directed his famous plays such as "Poparach", "Hour (o) local time", "Killer decision" and others. Vladimir Mashkov is also known for directing the films "Kazim Yatim" and "Baba". He has filmed more than 60 feature films, won the Golden Eagle, Tephy and Nika cinemas and television awards. Oleg Tabakov died on March 12 at the age of 83. Source: Novosti Yevgeny Diakonov
Read more